CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 65 filers reported holding CHEMOCENTRYX INC in Q4 2014. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $103,000 | -20.2% | 13,828 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $129,000 | +27.7% | 13,828 | 0.0% | 0.00% | – |
Q1 2017 | $101,000 | -10.6% | 13,828 | -9.5% | 0.00% | – |
Q4 2016 | $113,000 | +22.8% | 15,277 | 0.0% | 0.00% | – |
Q3 2016 | $92,000 | -78.7% | 15,277 | -84.1% | 0.00% | -100.0% |
Q2 2016 | $431,000 | +817.0% | 96,077 | +414.0% | 0.00% | – |
Q1 2016 | $47,000 | -68.9% | 18,691 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $151,000 | +33.6% | 18,691 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $113,000 | -26.6% | 18,691 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $154,000 | +1.3% | 18,691 | -6.9% | 0.00% | 0.0% |
Q1 2015 | $152,000 | +6.3% | 20,083 | -4.1% | 0.00% | 0.0% |
Q4 2014 | $143,000 | +52.1% | 20,945 | 0.0% | 0.00% | – |
Q3 2014 | $94,000 | -21.7% | 20,945 | +1.9% | 0.00% | – |
Q2 2014 | $120,000 | -4.0% | 20,554 | +8.8% | 0.00% | -100.0% |
Q1 2014 | $125,000 | +14.7% | 18,889 | 0.0% | 0.00% | – |
Q4 2013 | $109,000 | 0.0% | 18,889 | -3.2% | 0.00% | – |
Q3 2013 | $109,000 | -26.8% | 19,523 | +85.3% | 0.00% | -100.0% |
Q2 2013 | $149,000 | – | 10,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |